Phase 3 trial results show roflumilast cream 0.05% to be a safe and effective treatment for children with atopic dermatitis.

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.

An Australian-first study has found that certain natural fats which exist in the skin of babies, called lipids, are linked to the development of ...

Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...

Let's uncover the hidden truths behind why your eczema keeps returning and what you can do to get long-term relief.

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Many TikTokers attest to its deeply hydrating and skin-improving ability — notably, former reality TV star Lo Bosworth, who ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...